This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
    • New-Drug Briefs
    • What's New
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Hang on a second…

This CME Activity has expired and is no longer available for credit.

New-Drug Briefs (March 2017)

New-Drug Briefs (March 2017)



Time to Complete

1 hour


March 1, 2017


March 1, 2018
Add to Queue

Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM

Accredited Provider

This program is provided by Haymarket Medical Education.

Commercial Supporter

There is no commercial support for this activity.

Statement of Need

To maintain and deliver the highest standard of care for their patients, it is essential that clinicians are able to incorporate timely, relevant, and evidence-based pharmacology information into their therapeutic treatment decisions. This CME activity provides information on indications, risk/benefits, research/clinical trial data, contraindications, and applications within a clinical setting on a broad spectrum of medications that have been recently approved, have new indications, or have recently received updated information.

In addition, clinicians on the front lines in primary care need to keep up with the latest clinical news in order to stay informed of the most up-to-date health care information and trends in pharmacotherapeutic management.


CME Editor
Ana Marija Djordjevic, PharmD

Post Doctoral Fellow, Medical Affairs
Haymarket Medical Education

Dr. Djordjevic has no relevant financial relationships to disclose.

CME Reviewer
Ruchit Parikh, PharmD

Associate Medical Director
Haymarket Medical Education

Dr. Parikh has no relevant financial relationships to disclose.

Intended Audience

This activity has been designed to meet the educational needs of primary-care clinicians who need to keep abreast of current evidence-based pharmacology information and pertinent clinical news.

Educational Objectives

After participating in this activity, clinicians should be better able to:

  • Analyze potential pharmacotherapeutic applications for the reviewed agent(s), with consideration of safety issues that may preclude use or warrant patient monitoring
  • Compare dosage, route of administration, efficacy, and/or safety for the agent(s) discussed in this activity with other members of the same therapeutic class
  • Evaluate clinical news for application in professional practice
  • Conflict of Interest Disclosure Policy

    In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Planners' and Managers' Disclosures

    The Haymarket staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.




    AMA PRA Category 1 Credit(s)TM

    Accreditation Statement

    Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Designation Statement

    Haymarket Medical Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Disclosure of Unlabeled Use

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Haymarket Medical Education (HME) does not recommend the use of any agent outside of the labeled indications.

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of HME. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


    To obtain credit, a post-test score of 70% or better is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can then access at any time.

    For any CME-related questions, please call (201) 799-4827 or email

    Privacy Policy


    Hardware and Software Requirements
    • A computer with an internet connection
    • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
    • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
    Add to Queue